Comparison of Medication Adherence Between Once and Twice Daily Tacrolimus in Stable Renal Transplant Recipients

NCT01334333 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Renal Disease
Renal Transplant

Interventions

DRUG: Tacrolimus - Prograf® twice daily formulation
DRUG: Tacrolimus - Advagraf® once daily formulation

Sponsor

University of British Columbia

Collaborators

[object Object]
[object Object]